{"id":"W2891861352","doi":"10.1200/jco.2016.34.15_suppl.e14577","title":"Determination of optimal dose and treatment schedule of the immunotherapeutic vaccine, DPX-Survivac, for combination immunotherapy treatment of ovarian, fallopian tube or peritoneal cancer (OC): A phase Ib study.","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Immunovaccine (Canada); University Health Network","funders":"","keywords":"Medicine; Survivin; ELISPOT; Immunogenicity; Adjuvant; Immune system; Immunology; Ovarian cancer; Immunotherapy; Adverse effect; Vaccination; Oncology; CD8; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005144523,0.0004423066,0.0006908989,0.0003118942,0.0001401573,0.0003646752,0.0003994796,0.0004797934,0.001866485],"category_scores_gemma":[0.0002982105,0.0002194316,0.0003786993,0.0002564545,0.0003045979,0.0003548218,0.0002096489,0.0009761164,0.0002709466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003785177,"about_ca_system_score_gemma":0.0006441873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003146341,"about_ca_topic_score_gemma":0.0006667808,"domain_scores_codex":[0.9998637,0.00003721395,0.00001031022,0.00003011784,0.00002395008,0.00003452959],"domain_scores_gemma":[0.9998587,0.00002209031,0.00004444341,0.00001634395,0.00001000196,0.00004837481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1489392,0.07905254,0.01071185,0.001529698,0.0005406698,0.0002159873,0.0003892754,0.008309203,0.5071996,0.0005588586,0.001926738,0.2406263],"study_design_scores_gemma":[0.05146239,0.8300108,0.01624895,0.00009586173,0.0006006697,0.0004968769,0.0001126456,0.003396729,0.09043288,0.0001936279,0.006912637,0.00003587106],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964199,0.001448396,0.0006012189,0.00006282423,0.00004059716,0.0007711066,0.0001515581,0.00001883351,0.0004856342],"genre_scores_gemma":[0.9953321,0.001037702,0.001874267,0.00008242467,0.00003083856,0.0007638038,0.0003164625,0.000008735283,0.0005537508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001866485,"threshold_uncertainty_score":0.006244004,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09811844666618247,"score_gpt":0.4476500338916469,"score_spread":0.3495315872254644,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}